4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-003989
Options or other derivatives
- CEO, CFO, Director acquired 131,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Finley John David CEO, CFO, Director | 2023-02-06 | Grant or award · Restricted Stock Units | +41,700 | 41,700 | D | ||
| Finley John David CEO, CFO, Director | 2023-02-06 | Grant or award · Restricted Performance Stock Units | +32,500 | 32,500 | D | ||
| Finley John David CEO, CFO, Director | 2023-02-06 | Grant or award · Common Stock Purchase Option | +57,200 | 57,200 | D | ||
Loading xslF345X03/ownership.xml…